Iopromide

Iopromide

Clinical data
Trade names	Ultravist
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Pregnancy category	AU: B2
Routes of administration	Intravascular
ATC code	V08AB05 (WHO)
Legal status
Legal status	US: ℞-only
Pharmacokinetic data
Protein binding	~1%
Metabolism	None
Elimination half-life	2 hours
Excretion	Kidneys
Identifiers
IUPAC name 1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-1-N-methylbenzene-1,3-dicarboxamide
CAS Number	73334-07-3 N
PubChem CID	3736
DrugBank	DB09156 Y
ChemSpider	3605 N
UNII	712BAC33MZ
KEGG	D01893 Y
ChEBI	CHEBI:63578 N
ChEMBL	ChEMBL1725 N
CompTox Dashboard (EPA)	DTXSID0023163
ECHA InfoCard	100.070.330
Chemical and physical data
Formula	C18H24I3N3O8
Molar mass	791.11187 g·mol−1
3D model (JSmol)	Interactive image
SMILES CN(CC(CO)O)C(=O)c1c(c(c(c(c1I)NC(=O)COC)I)C(=O)NCC(CO)O)I
InChI InChI=1S/C18H24I3N3O8/c1-24(4-9(28)6-26)18(31)12-13(19)11(17(30)22-3-8(27)5-25)14(20)16(15(12)21)23-10(29)7-32-2/h8-9,25-28H,3-7H2,1-2H3,(H,22,30)(H,23,29) N Key:DGAIEPBNLOQYER-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Iopromide is an iodinated contrast medium for X-ray imaging. It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use; i.e., it is injected into blood vessels.

It is commonly used in radiographic studies such as intravenous urograms, brain computer tomography (CT) and CT pulmonary angiograms (CTPAs).

Medical uses

The radiocontrast agent is given intravenously in computed tomography (CT) scans, angiography and excretory urography.

External links

• Bayer Schering Pharma global Ultravist Website